Agonists and antagonists of prolixin for the treatment of...

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C530S350000

Reexamination Certificate

active

10496757

ABSTRACT:
The present invention relates to the field of metabolic research, in particular the discovery of compounds effective for reducing body mass and useful for treating obesity-related diseases and disorders. The obesity-related diseases or disorders envisioned to be treated by the methods of the invention include, but are not limited to, hyperlipidemia, atherosclerosis, insulin resistance, diabetes, and hypertension. In particular, the invention provides for methods of identifying and using AGONISTS and ANTAGONISTS of PROLIXIN activity, wherein said activity is selected from the group consisting of lipid partitioning, lipid metabolism, and insulin-like activity.

REFERENCES:
patent: 6344441 (2002-02-01), Bihain et al.
patent: 6461821 (2002-10-01), Matsuzawa et al.
patent: 6566332 (2003-05-01), Fruebis et al.
patent: 6579852 (2003-06-01), Fruebis et al.
patent: 6867189 (2005-03-01), Lucas et al.
patent: 6946444 (2005-09-01), Bihain et al.
patent: 6967091 (2005-11-01), Fruebis et al.
patent: 6989367 (2006-01-01), Fruebis et al.
patent: 2002/0151498 (2002-10-01), Bihain et al.
patent: 2003/0092164 (2003-05-01), Gross et al.
patent: 2003/0215836 (2003-11-01), Young et al.
patent: 2003/0224501 (2003-12-01), Young et al.
patent: 2005/0003997 (2005-01-01), Lucas et al.
patent: 2005/0054565 (2005-03-01), Lucas et al.
patent: 2006/0089311 (2006-04-01), Dialynas et al.
patent: 1033134 (2000-09-01), None
patent: WO 99/59618 (1999-11-01), None
patent: WO 00/68380 (2000-11-01), None
patent: WO 00/73448 (2000-12-01), None
patent: WO 01/51645 (2001-07-01), None
patent: WO 02/38766 (2002-05-01), None
Thompson, J.S. et al., “BAFF-R, a Newly Identified TNF Receptor That Specifically Interacts with BAFF”Science, Sep. 14, 2001, pp. 2108-2111, vol. 293, No. 5537.
Yan, M. et al. “Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency”Current Biology, Oct. 2, 2001, pp. 1547-1552, vol. 11, No. 19.
U.S. Appl. No. 11/132,814, filed May 19, 2005, claims only.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Agonists and antagonists of prolixin for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Agonists and antagonists of prolixin for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agonists and antagonists of prolixin for the treatment of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3909085

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.